Target intelligence / Profile preview

DNMT3L Antisense RNA 1 (DNMT3L-AS1)

Target
DNMT3L-AS1
Molecular classification
Other (Long non-coding RNA)
01

Overview

DNMT3L Antisense RNA 1 (DNMT3L-AS1) is a non-coding RNA transcribed from the antisense strand at the DNMT3L locus[3]. DNMT3L itself is a regulatory protein involved in the establishment of DNA methylation patterns, especially during germ cell development, but DNMT3L-AS1 refers to an RNA gene rather than a protein product[6][7]. The protein-coding DNMT3L is important for genomic imprinting, acts as a cofactor for DNA methyltransferases (DNMT3A and DNMT3B), and interacts with chromatin via histone modifications[1][6][7]. Regulatory non-coding RNAs such as DNMT3L-AS1 may potentially modulate the expression or activity of DNMT3L and associated methylation machinery, and similar antisense RNAs have been shown to affect chromatin state and gene regulation[4][5]. However, there is currently no experimental evidence specifically detailing the function, mechanism, or clinical relevance of DNMT3L-AS1[3]. Key contextual notes: - DNMT3L-AS1 should not be confused with the protein DNMT3L, which is highly relevant in epigenetics and gene regulation but is not itself a DNA methyltransferase enzyme[2][6][7]. - The limited available information supports DNMT3L-AS1 as a valid lncRNA nomenclature but does not indicate it is a clinically actionable or well-characterized molecular target. If you require structured data on the protein DNMT3L, which is a widely studied methyltransferase cofactor, please specify; most functional, therapeutic, biological, and disease-association data are available for DNMT3L protein, not for DNMT3L-AS1.

Other names
DNMT3L Antisense RNA 1DNMT3L-AS1
02

Biological functions

Incomplete; based on available information for DNMT3L-AS1, specific biological functions remain undefined. In analogy to other antisense RNAs, possible roles may include gene regulation (e.g., regulation of DNMT3L or DNMT3A expression or activity)[3][4].
03

Disease associations

Incomplete; currently, no direct association with specific diseases is clearly described for DNMT3L-AS1. LncRNAs in general can be involved in various pathologies, but DNMT3L-AS1 has not been specifically implicated.

Beyond the preview

Go deeper on DNMT3L Antisense RNA 1 (DNMT3L-AS1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on DNMT3L Antisense RNA 1 (DNMT3L-AS1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call